Amneal Pharmaceuticals Company Profile Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amneal pharmaceuticals company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amneal Pharmaceuticals Company Profile Get Rating Today - Breaking & Trending Today

Financial Contrast: Amneal Pharmaceuticals (NASDAQ:AMRX) versus Radius Health (NASDAQ:RDUS)

Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) and Radius Health (NASDAQ:RDUS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Risk and Volatility Amneal Pharmaceuticals has a beta of […] ....

United States , New Jersey , Amneal Pharmaceuticals , Radius Health Company Profile Get Rating , Department Of Defense , Given Radius Health , Eisai Co , M Company , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile Get Rating , Department Of Veterans Affairs , Radius Health , Radius Health Inc , Atlas Holdings Inc , Duke University , Get Rating , Pharmaceuticals Company Profile , Atlas Holdings , Health Company Profile , Ipsen Pharma , Teijin Limited , Nasdaq Amrx , Stock Comparison , Stock Analysis ,

Zacks: Analysts Expect Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Will Post Quarterly Sales of $534.46 Million

Equities analysts predict that Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Rating) will announce $534.46 million in sales for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Amneal Pharmaceuticals’ earnings, with estimates ranging from $528.92 million to $544.80 million. Amneal Pharmaceuticals posted sales of $535.08 million in the same quarter last […] ....

Amneal Pharmaceuticals , Zacks Investment Research , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile Get Rating , Get Rating , Amneal Pharmaceutical , Pharmaceuticals Company Profile , Nasdaq Amrx ,

$0.19 EPS Expected for Amneal Pharmaceuticals, Inc. (NYSE:AMRX) This Quarter

Wall Street analysts expect Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) to report earnings per share (EPS) of $0.19 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Amneal Pharmaceuticals’ earnings, with estimates ranging from $0.18 to $0.21. Amneal Pharmaceuticals posted earnings per share of $0.25 in the […] ....

Amneal Pharmaceuticals , Zacks Investment Research , Nuveen Asset Management , Blackrock Inc , Amneal Pharmaceuticals Inc , Vanguard Group Inc , Amneal Pharmaceuticals Company Profile Get Rating , Wall Street , Get Rating , Zacks Investment , Amneal Pharmaceutical , Investment Research , Asset Management , Pharmaceuticals Company Profile , Nyse Amrx ,

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Expected to Post Earnings of $0.20 Per Share

Wall Street analysts forecast that Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Rating) will announce earnings of $0.20 per share for the current quarter, according to Zacks. Four analysts have issued estimates for Amneal Pharmaceuticals’ earnings. The highest EPS estimate is $0.24 and the lowest is $0.18. Amneal Pharmaceuticals reported earnings of $0.25 per share during […] ....

Amneal Pharmaceuticals , Zacks Investment Research , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile Get Rating , Wall Street , Get Rating , Amneal Pharmaceutical , Investment Research , Pharmaceuticals Company Profile , Nasdaq Amrx ,

$500.68 Million in Sales Expected for Amneal Pharmaceuticals, Inc. (NYSE:AMRX) This Quarter

Wall Street brokerages predict that Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) will post sales of $500.68 million for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Amneal Pharmaceuticals’ earnings, with estimates ranging from $493.50 million to $508.70 million. Amneal Pharmaceuticals reported sales of $493.11 million during the same […] ....

Amneal Pharmaceuticals , Geode Capital Management , Zacks Investment Research , Nuveen Asset Management , Blackrock Inc , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile Get Rating , Wall Street , Get Rating , Zacks Investment , Amneal Pharmaceutical , Investment Research , Asset Management , Capital Management , Pharmaceuticals Company Profile , Nyse Amrx ,